About us
NewCan Biotech Limited was established in 2021 and is primarily engaged in the research, development, production, and sales of sugars, nucleosides, nucleotides, phosphorylated monomers, as well as next-generation antiviral and antitumor drug intermediates.
Looking ahead, we will continue to uphold an innovative spirit, enhance our technological capabilities, and provide customers with high-quality products and services.
We aim to become leaders and innovators in the industry by delivering exceptional value and contributing to advancements in pharmaceuticals, biotechnology, and life sciences.